Patents by Inventor Michael Guttadauro
Michael Guttadauro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230321243Abstract: A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier. The treatment area is covered with the low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area.Type: ApplicationFiled: May 5, 2023Publication date: October 12, 2023Applicant: DUSA Pharmaceuticals, Inc.Inventors: Scott Lundahl, Michael Guttadauro
-
Patent number: 11690914Abstract: A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier. The treatment area is covered with the low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area.Type: GrantFiled: July 28, 2022Date of Patent: July 4, 2023Assignee: DUSA Pharmaceuticals, Inc.Inventors: Scott Lundahl, Michael Guttadauro
-
Patent number: 11571478Abstract: A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier. The treatment area is covered with the low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area.Type: GrantFiled: September 28, 2021Date of Patent: February 7, 2023Assignee: DUSA PHARMACEUTICALS, INC.Inventors: Scott Lundahl, Michael Guttadauro
-
Publication number: 20220370610Abstract: A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier. The treatment area is covered with the low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area.Type: ApplicationFiled: July 28, 2022Publication date: November 24, 2022Applicant: DUSA Pharmaceuticals, Inc.Inventors: Scott LUNDAHL, Michael GUTTADAURO
-
Patent number: 11433133Abstract: A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier. The treatment area is covered with the low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area.Type: GrantFiled: September 28, 2021Date of Patent: September 6, 2022Assignee: DUSA PHARMACEUTICALS, INC.Inventors: Scott Lundahl, Michael Guttadauro
-
Publication number: 20220008538Abstract: A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier. The treatment area is covered with the low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area.Type: ApplicationFiled: September 28, 2021Publication date: January 13, 2022Applicant: DUSA Pharmaceuticals, Inc.Inventors: Scott Lundahl, Michael Guttadauro
-
Patent number: 11135293Abstract: A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier. The treatment area is covered with the low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area.Type: GrantFiled: December 2, 2020Date of Patent: October 5, 2021Assignee: DUSA PHARMACEUTICALS, INC.Inventors: Scott Lundahl, Michael Guttadauro
-
Patent number: 11077192Abstract: A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier. The treatment area is covered with the low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area.Type: GrantFiled: June 12, 2019Date of Patent: August 3, 2021Assignee: DUSA PHARMACEUTICALS, INC.Inventors: Scott Lundahl, Michael Guttadauro
-
Publication number: 20210085788Abstract: A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier. The treatment area is covered with the low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area.Type: ApplicationFiled: December 2, 2020Publication date: March 25, 2021Applicant: DUSA Pharmaceuticals, Inc.Inventors: Scott LUNDAHL, Michael GUTTADAURO
-
Publication number: 20190290763Abstract: A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier. The treatment area is covered with the low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area.Type: ApplicationFiled: June 12, 2019Publication date: September 26, 2019Applicant: DUSA Pharmaceuticals, Inc.Inventors: Scott LUNDAHL, Michael GUTTADAURO
-
Patent number: 10357567Abstract: A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier. The treatment area is covered with the low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area.Type: GrantFiled: January 12, 2018Date of Patent: July 23, 2019Assignee: DUSA Pharmaceuticals, Inc.Inventors: Scott Lundahl, Michael Guttadauro
-
Publication number: 20190216927Abstract: A method of enhancing penetration of a topical composition of 5-aminolevulinic acid (ALA) into tissue for photodynamic therapy includes topically applying ALA to a treatment area to be treated with photodynamic therapy. The method further includes, after the ALA is applied to the treatment area, covering the treatment area with a low density polyethylene barrier. The treatment area is covered with the low density polyethylene barrier prior to light treatment to minimize transepidermal water loss from the treatment area.Type: ApplicationFiled: January 12, 2018Publication date: July 18, 2019Applicant: DUSA Pharmaceuticals, Inc.Inventors: Scott LUNDAHL, Michael Guttadauro
